Закрити ×
20 травня 2026 року 20.05.26

Mykhaylo Delva, MD, PhD.

Mykhaylo Delva, MD, PhD.

Neurology

 

Highlights

Languages
  • Ukrainian, English
Gender
  • Male
PSMU Affiliations:
  • Department of Neurological Diseases
Location:

 

About Prof. Mykhaylo Delva

Primary Academic Title
  • Doctor of Medical Sciences, since 2014
  • Professor (Neurology), since 2018
  • Clinician at the Poltava Regional Clinical Hospital named after M.V. Sklifosovsky (Neurology)
Professional Titles
  • Head of Department of Neurological Diseases since 2019.
  • Chairman of Neurologists Society of Poltava Region since 2011.
  • Board Member of the public association “Association of Neurologists, Psychiatrists and Narcologists of Ukraine” since 2024.

 

Background

Mykhaylo Delva is a Ukrainian Neurologist, Head of Department of Neurological Diseases at Poltava State Medical University.

He is the author and co-author of more than 200 scientific and research works, of which 21 articles are in journals indexed by "Scopus" database (h-index: 7) and over 30 certificates and patents for inventions.

Facebook https://www.facebook.com/profile.php?id=100007679884054
Research Interests
  • Post-stroke cognitive disorders
  • Neuropathic pain
  • Primary headaches
  • Multiple sclerosis

Researcher unique identifier: 0000-0001-5648-7506

Scopus Author ID 57194852501

 

Expertise

Education

1997 – Physician (corresponding to MD), Ivano-Frankivsk State Medical Institute, Ivano-Frankivsk, Ukraine.

2002 – Candidate of Medical Sciences (corresponding to PhD), Kharkiv State Medical University, Kharkiv, Ukraine. Title of PhD thesis: “Features of the brain arterial circle in different structural variants of its posterior section”.

2014 – Doctor of Medical Sciences (Dr. habil.) in Neurology, P.L. Shupyk National Medical Academy of Postgraduate Education., Kyiv, Ukraine. Title of Postdoctoral thesis: “Ischemic stroke and obesity: the rationale for pathogenetic approaches to diagnosis and treatment”.

2018 – Professor (Neurology), Higher Attestation Commission.

Selected Publications
  • Delva M, Skoryk K, Delva I. Predictors of neuropathic dysesthetic pain occurrence and chronification in multiple sclerosis (2-year prospective study). Acta Bio Medica: Atenei Parmensis. 2023 Dec 5;94(6):e2023229. doi: 10.23750/abm.v94i6.14609.
  • Awuah WA, Tan JK, Shkodina AD, Ferreira T, Adebusoye FT, Mazzoleni A, Wellington J, David L, Chilcott E, Huang H, Abdul-Rahman T., Delva M. Hereditary spastic paraplegia: Novel insights into the pathogenesis and management. SAGE open medicine. 2024 Jan;12:20503121231221941. doi: 10.1177/20503121231221941.
  • Shkodina AD, Bardhan M, Chopra H, Anyagwa OE, Pinchuk VA, Hryn KV, Kryvchun AM, Boiko DI, Suresh V, Verma A, Delva MY. Pharmacological and non-pharmacological approaches for the management of neuropathic pain in multiple sclerosis. CNS drugs. 2024 Mar;38(3):205-24. doi: 10.1007/s40263-024-01072-5.
  • Shkodina AD, Tarianyk KA, Delva MY, Khan AA, Malik A, Fatima S, Alexiou A, Rahman MH, Papadakis M. Influence of sleep quality, excessive daytime sleepiness, circadian features and motor subtypes on depressive symptoms in Parkinson's disease. Sleep Medicine. 2025 Jan 1;125:57-64. doi: 10.1016/j.sleep.2024.11.024.
Honors and Awards

2011 – Diploma for the Excellent Case Report Presentation (Salzburg CHOP Seminar in Neurology, Open Medical Institute).

2013 – International Scholarship Award for Research, American Academy of Neurology (San Diego, USA).

Memberships
  • Member of Ukrainian Stroke Medicine Society.
  • Member of Ukrainian League against Epilepsy.
  • Member of the International Parkinson and Movement Disorders Society (MDS)

 

Professional Activities

  • Chairman of the Coordination Council of the Center for Multiple Sclerosis Patients in Poltava region, 2019 – present.
  • Head of the educational, diagnostic and treatment center for patients with primary headache in Poltava region, 2020 – present.
  • Reviewer and editorial board member of scientific journals “International Neurological Journal” (Scopus), “Bulletin of Problems Biology and Medicine”, “Actual Problems of the Modern Medicine” (Ukraine).
  • Member of the multidisciplinary workgroups on the creation of industry standards of medical care on “Autoimmune diseases of the nervous system and neuromuscular diseases”, “Alzheimer's disease, vascular dementia and other dementias due to neurodegenerative diseases”, “Parkinson's disease and other neurodegenerative diseases associated with movement disorders”.
  • 2020 – present: Principal Investigator in clinical trials.
Additional Training
  • 2008 – present: ICH/GCP (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use/Good Clinical Practice) trainings.